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Abstract 3-Ketosteroid-D1-dehydrogenase (KstD), a key
enzyme in microbial steroid catabolism, catalyzes the trans-
axial elimination of the C1 and C2 hydrogen atoms of the
A-ring from the polycyclic ring structure of 3-ketosteroids,
and it was usually used to transform androst-4-ene-3,17-dione
(AD) to produce androsta-1,4-diene-3,17-dione. Here, the
KstD from Gordonia neofelifaecis was expressed efficiently
in Escherichia coli. E. coli cells expressing KstD3gor were
subjected to the investigation of dehydrogenation activity for
different steroids. The results showed that KstD3gor has a clear
preference for steroid substrates with 3-keto-4-ene configu-
ration, and it exhibits higher activity towards steroid substrates
carrying a small or no aliphatic side chain than towards sub-
strates having a bulky side chain at the C-17 atom. The
recombinant strain could efficiently convert androst-4,9(11)-
dien-3,17-dione into androst-1,4,9(11)-trien-3,17-dione (with
conversion rate of 96%). 1(2)-Dehydrogenation of androst-
4,9(11)-dien-3,17-dione is one of the key steps in glucocor-
ticoid production. To the best of our knowledge, this is the first
study reporting on the conversion of androst-4,9(11)-dien-
3,17-dione catalyzed by recombinant KstD; the expression
system of KstD3gor reported here would have an impact in the
industrial production of glucocorticoid in the future.
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Introduction
Significant progress has been made over the last ten years in
the use of enzymes andmicroorganisms for themanufacturing
of complex chemical compounds and replacing multi-steps
chemical syntheses. Actinobacteria are known as efficient
biocatalysts of steroid bioconversion since 1913 (Tak 1942).
However, the recent advances in genome sequencing and
bioinformatics technologies provided tools for identification
of new players in cholesterol bioconversion. Although ster-
oids are highly resistant to biodegradation, many bacteria use
them as a source of carbon and energy (Garcı´a et al. 2012).
Microbial transformation could be carried out under mild
reaction conditions with excellent yields of products and
remarkable regio- and stereo-selectivity, which is hardly
available for chemical synthesis. Therefore, for producing
novel steroidal drugs and generating active pharmaceutical
ingredients, microbial transformation is employed as a novel,
efficient and economical tool (Donova 2007; Garcı´a et al.
2012; Yang et al. 2015). For example, side chains of phytos-
terol, a byproduct from soybeans, sugar and paper industries,
can be selectively degraded by a process similar to the b-
oxidation of fatty acids, yielding 17-ketosteroids (Wei et al.
2010). One of the products of this degradation, 9a-hydroxy-
androst-4-ene-3,17-dione, and itsD9-analog are considered as
the most important intermediates for the synthesis of corti-
coids such as prednisolone, betamethasone, dexamethasone,
and triamcinolone (Fokina and Donova 2003; Yuan et al.
2015). The efficiency of enzymatic processes and purity of
their products have obvious advantages in comparison with
multi-steps chemical syntheses of hormonal drugs. However,
the development of steroid biotechnology requires further
studies of microorganisms able to degrade/modify steroids as
well as enzymes catalyzing these reactions on the molecular
level (Yang et al. 2015).
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The degradation of cholesterol or its derivatives begins
with the transformation of cholesterol to cholest-4-en-3-one
by a cholesterol oxidase (Shao et al. 2015). The subsequent
catabolism involves elimination of the alkyl side chain fol-
lowed by the opening of the rings A/B and rings C/D. A
3-ketosteroid D1-dehydrogenase (KstD) [EC 1.3.99.4], cat-
alyzing the elimination of the hydrogen atoms of the C-1 and
C-2 in the A-ring from the polycyclic ring structure of
3-ketosteroids, is a key enzyme in microbial steroid catabo-
lism needed for the opening of the steroid B-ring (Ferna´ndez
de Las Heras et al. 2012; Zhang et al. 2013). KstD is a FAD-
dependent enzyme, the natural electron acceptor appears to
be vitamin K2 (Choi et al. 1995a), and they can transfer
electrons to N-methyl phenazolium sulfate. KstDs were
found in various bacteria, including Mycobacterium sp.,
Rhodococus sp., Pseudomonas sp. and Arthrobacter sp. (Choi
et al. 1995b; Molnar et al. 1995; van der Geize et al. 2000;
Brzostek et al. 2005; Knol et al. 2008). They display a broad
substrate spectrum. The KstD1SQ1 (KstD1 from Rhodococcus
erythropolis SQ1) and KstD2SQ1 enzymes (KstD2 from
Rhodococcus erythropolis SQ1) were specific for steroids
with the 3-keto-4-ene structure such as 9a-hydroxy-androst-
4-ene-3,17-dione (Knol et al. 2008). KstD3SQ1 (KstD3 from
Rhodococcus erythropolis SQ1) had a clear preference for
3-ketosteroids with a saturated A-ring. The role of three
KstDs from Rhodococcus ruber strain Chol-4 was studied in
the steroid metabolism (Ferna´ndez de Las Heras et al. 2012).
KstD proteins were expressed in Escherichia coli (Wei
et al. 2014), Bacillus subtilis (Zhang et al. 2013), Strepto-
myces lividans (Choi et al. 1995a), Rhodococcus erythro-
polis (Knol et al. 2008), Mycobacterium neoaurum (Morii
et al. 1998), etc., and used to convert androst-4-ene-3,17-
dione (AD) into androsta-1,4-diene-3,17-dione (Choi et al.
1995b; Morii et al. 1998; Knol et al. 2008; Zhang et al.
2013; Wei et al. 2014). An interesting possibility to use
KstD for the 1(2)-dehydrogenation of androst-4,9(11)-dien-
3,17-dione [4,9(11)-AD] (a step of the pathway for gluco-
corticoid production, as shown in Fig. 1) has not been tested.
Gordonia neofelifaecis NRRL B-59395 was initially
isolated from fresh faeces of a clouded leopard (Neofelis
nebulosa) for its ability to degrade cholesterol (Liu et al.
2011). In spite of a significant number of known acti-
nobacteria that could degrade/modify steroids, only a few
genomes of them have been completely sequenced to
identify all sterol catabolic genes. We sequenced G.
neofelifaecis NRRL B-59395 genome and found 5 putative
genes encoding KstD (Ge et al. 2011; Li et al. 2014). We
also studied the substrate specificity of these KstDs in our
former study (Zhang et al. 2015). One enzyme, KstD3gor,
had the broadest spectrum of substrate specificity,
exhibiting activity to progesterone, 16a, 17a-epoxypro-
gesterone and cholest-4-en-3-one.
In this work, we cloned KstD3gor gene into E. coli
vector, expressed the recombinant enzyme and character-
ized its enzyme specificity and selectivity. Our results
indicated that KstD3gor could have a possible application
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(China). 16a,17a-epoxyprogesterone, dehydroandros-
terone, were obtained from XianJu Pharmaceutical Com-
pany Ltd. (Zhejiang Province, China) with purity of 98%.
Cholesterol (purity C99%), progesterone (purity C99%),
5a-cholesteran-3b-ol (with purity of 92%), 3b-hydrox-
ypregn-5-en-20-one (with purity of 92%), phenazine
methosulfate (PMS, purity C90%), nitro blue tetrazolium
(with purity of 98%), and dimethylformamide were pur-
chased from Sigma (USA). Cholest-4-en-3-one, androst-4-
en-3,17-dione (AD), (25R)-cholesten-26-oic acid with
purity of 99% were synthesized and characterized using
1HNMR, 13C NMR, IR, and TOF–MS as it was done in our
previous studies (Liu et al. 2011; Wu et al. 2015). (25R)-
cholesten-26-oic acid was prepared as recommended
(Martin et al. 2009). Restriction enzymes, dNTPs, Taq
polymerase were purchased from TaKaRa Co. (Dalian,
China).
Bacterial strains
Gordonia neofelifaecis (NRRL B-59395) was preserved in
our laboratory (Ge et al. 2011) and cultivated in liquid LB
medium (Luria–Bertani broth) at 37 C. The strain had
been originally isolated from the faeces of Neofelis nebu-
losa. Escherichia coli DH5a and E. coli BL21 (purchased
from Transgen Biotech Co., Ltd, Beijing, China) were
grown in LB broth or Super Optimal Broth (SOB, 2%
peptone, 0.5% Yeast extract, 10 mM NaCl, 2.5 mM KCl,
10 mM MgCl2, 10 mM MgSO4) (Hanahan 1983) at 37 C/
200 rpm. Kanamycin (25 lg/mL) was added to the growth
medium when necessary. For growing on solid medium,
2% (w/v) agar was added.
Construction and expression of KstD3gor in E. coli
The KstD3gor gene was amplified from previously cloned
KstD3gor construct (Zhang et al. 2015) and cloned into the
Nde I/BamH I restriction sites of pET-28a(?) vector (No-
vagen), giving the construct pET28a-KstD3. Recombinant
DNA techniques were done according to standard protocols
(Sambrook and Russell 2001). E. coli transformation was
performed as described previously (Chung et al. 1989). The
DNA was isolated using the Plasmid Mini Kit (Omega,
USA) according to the manufacturer’s instructions. DNA
sequence was verified by sequencing service provided by
the Beijing Genome Institute Sequence Facility (Shenzhen,
China).
Expression of KstD3gor in E. coli and preparation
of clarified lysate
Recombinant KstD3gor protein was expressed in
BL21(DE3) cells. E. coli cells transformed with pET28a-
KstD3 construct were grown overnight (18 h) at 37 C in
10 mL of LB medium containing 25 lg/mL kanamycin
(the same concentration was used in all cultivation pro-
cedures) in a 50-mL Erlenmeyer flask. Ten mL of this
culture was inoculated into 500 mL of LB medium con-
taining antibiotic in a 2000-mL Erlenmeyer flask and
incubated at 30 C until the OD600 reached *0.6. Then,
the culture was induced with 1 mM isopropyl b-D-1-
thiogalactopyranoside (IPTG), and incubated with shak-
ing (200 rpm) at 30 C for 6 h. The cells were harvested
by centrifugation at 10,000 rpm for 10 min. The cell
pellet was washed for three times with 10 mL of chilled
(4 C) 50 mM Tris–HCl buffer (pH 7.0) (every time,
centrifugation was performed at 10,000 rpm for 10 min at
4 C), resuspended in 10 mL of the same buffer and
sonicated using an ultrasonic homogenizer (JY92-II,
Scientz Biotechnology Co. Ltd., China) in an ice bath,
with 90 cycles of 5 s on and 5 s off at 220 W. The cell
lysates were centrifuged for 30 min at 18,000 rpm and
4 C. The supernatant (clarified lysate) and the washed
cell pellet were used for KstD activity gel assay or bio-
chemical assays for the measurements of bioconversion of
steroid substrates.
KstD activity staining on native PAGE
The cell extract was used for analysis of KstD activity on
native 12.5% PAGE (Knol et al. 2008). The KstD activity
was visualized by incubating native gels in 100 mL 50 mM
Tris–HCl buffer (pH 7.0) containing 3.1 mg phenazine
methosulphate, 2.9 mg androst-4-en-3, 17-dione dissolved
in ethanol and 41 mg nitroblue tetrazolium (NBT) dis-
solved in 70% dimethylformamide. The native gels were
stained for several hours until the appearance of distinct
purple-colored bands of the product of the reaction, for-
mazan on the gel. Then, the staining was stopped by
replacing the staining solution with 100 mL of 10% (v/v)
acetic acid.
Preparation of steroid-methyl-b-cyclodextrin (Me-b-
CD) complex (steroid-complex)
Steroid-methyl-b-cyclodextrin (Me-b-CD) complex
(steroid-complex) was prepared by the co-evaporation
method as previously reported (Manosroi et al. 2008).
Briefly, 0.2 mol of methyl-b-cyclodextrin and 0.1 mol of
steroid substrates were dispersed in 95% ethanol and
stirred with a speed of 200 rpm for 4 h at 37 C. Then,
ethanol was evaporated at 60 C on a Buchi model R-210
rotary evaporator (0.09 Mpa, with a speed of 60 rpm at
65 C) (The same parameters of the instrument were
used throughout the study to concentrate extraction
samples).
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Bioconversion of steroid substrates by KstD3gor-
expressing E. coli cells and extracts
The bioconversion of steroid substrate was performed in
100 mL Erlenmeyer flasks with the clarified lysates or E. coli
cells. To prepare E. coli cells, the cells expressing KstD3gor
were harvested by centrifugation from4 mL fresh culture, and
resuspended in 20 mL Tris–HCl buffer (pH 7.0) to the con-
centration of 5 9 107 CFU/mL. The clarified lysates from
4 mL fresh culture were prepared as described above. Then,
steroid complex was added to the 20 mL of cell suspension or
clarified lysate. The final concentration of each substrate was
2 g/L. The reaction mixture was incubated at 37 C with
shaking at 200 rpm for 10–24 h. Steroids were extracted from
themedium by adding the equivalent volume of ethyl acetate;
after phase separation, the upper organic phase was analyzed
by thin-layer chromatography (TLC). The TLC was per-
formed on0.25 mm-thick silica gelG (silica gel 254,Qingdao
Haiyang Chemical Co., Ltd.) with cyclohexane/ethyl acetate
(7:3, v/v) as the mobile phase. 10 lL sample of organic phase
was applied on TLC plate. The products of the enzymatic
reactionwere visualized by spraying amixture of sulfuric acid
and methanol (1:6, v/v) on the plates and heating them at
100 C until the colors developed. The extraction procedure
was repeated three times, and the steroid extract was dried by
reduced pressure distillation (0.09 MPa, 65 C) and further
separated by high-performance liquid chromatography
(HPLC) (Shimadzu, Kyoto, Japan). To perform HPLC anal-
ysis, samples were diluted to an appropriate concentration
(about 1 mg/mL)withmethanol and filtered through 0.22 lm
pore-size membranes. HPLC analysis was performed on an
Alltima C18 column (250 9 4.6 mm, 5 lm, Alltech, USA)
under the control of an HPLC system (Shimadzu, Japan)
equipped with an LC-20AB HPLC pump system and SPD-
20AUVdetector. TheHPLCwas performed usingmethanol–
water (6:4, v/v) as themobile phase at a flow rate of 1 mL/min.
The conversion rate of sterol was calculated according
to the following formula:
Conversion rate %ð Þ ¼ moles of product
moles of substrate converted
:
Purification and spectroscopic analysis
of transformation products
Purification of the products of bioconversion was performed
as previously described (Liu et al. 2011). Briefly, 500 mL of
the reaction mixture was extracted with 500 mL ethyl
acetate (v/v) at room temperature for 30 min. The organic
phase was collected and evaporated under reduced pressure.
The crude gum was dissolved in ethyl acetate, and applied to
a silica gel column (2.5 cm 9 30 cm), eluted with acetone/
ethyl acetate (the eluent system consisted of gradient mix-
tures of chloroform and acetone and ethyl acetate), at a flow
rate of 1 mL/min. Fractions of 10 mL were collected. The
fractions containing the same steroid intermediates were
pooled and concentrated in a rotary evaporator. Finally, the
product was recrystallized from anhydrous alcohol and was
subjected to 1HNMR, 13C NMR, or TOF–MS analysis.
Results
Expression of the catalytically active KstD3gor
in E. coli cells
To expand our knowledge about KstD3gor from G. neofeli-
faecis, the gene of this enzyme was sub-cloned into a
commercial E. coli vector pET28a(?) and recombinant
KstD3gor protein was expressed in BL21(DE3) cells. The
calculated molecular mass of KstD3gor (57 kDa) corre-
sponded to the most abundant band on the 10% SDS-PAGE
in the sample with induced expression of the protein
(Fig. 2a, lane 3). A significant amount of KstD3gor was
expressed as a soluble protein (Fig. 2a, lanes 3, 4).
Decreasing the temperature (from 30 to 25 C) and
increasing the induction time (from 4 to 6 h) led to a high
level of recombinant protein expression.
KstD activity staining on native PAGE confirmed the
expression of catalytically active enzyme. The clarified
lysates were prepared and assayed by native PAGE as
described in Sect. ‘‘Materials and methods’’. The electron
transfer from AD via phenazine methosulphate to NBT
catalyzed by KstD3gor resulted in the formation of a purple-
colored product of the reaction, formazan (Fig. 2b, lanes 2,
3). Meanwhile, no activity was detected in the negative
control sample (Fig. 2b, lane 1).
Bioconversion of steroid substrates by KstD3gor-
expressing E. coli cells and clarified lysates
The E. coli cells expressing KstD3gor were tested in the
dehydrogenation reaction of androst-4,9(11)-dien-3,17-
dione. The structures of the products were determined
using spectroscopic techniques including 1HNMR, 13C
NMR and TOF–MS. The TOF–MS spectra are shown in
Fig. 3a, TOF–MS m/z: 283.17[M?H]?, 305.15[M?Na]?.
1H NMR spectrum in CDCl3 (d, ppm): 0.89 (3H, s, H-18),
1.36 (3H, s, H-19), 5.59 (br t, 1H, H-11), 6.09 (1H, s, H-4),
6.30 (1H, dd, J = 10.2, 1.9 Hz, H-2), 7.27 (1H, d,
J = 10 Hz, H-1). 13C NMR spectrum in CDCl3 (d, ppm):
154.3 (C-1), 127.2 (C-2), 186.0 (C-3), 123.8 (C-4), 166.1
(C-5), 33.7 (C-6), 31.6 (C-7), 34.2 (C-8), 143.4 (C-9), 45.9
(C-10), 119.8(C-11), 33.5 (C-12), 46.0 (C-13), 48.1 (C-14),
26.4 (C-15), 36.1 (C-16), 220.2 (C-17), 13.7 (C-18), 22.8
(C-19). The result showed that the product reduces two
mass units from androst-4,9(11)-dien-3,17-dione (284.39),
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suggesting that dehydrogenation reaction has occurred at
the C-1 and C-2 in the A-ring.
In a typical bioconversion experiment, 500 mL of
KstD3gor-expressing E. coli cells supplemented with 2 g/L
androst-4,9(11)-dien-3,17-dione produced 1.94 g/L
androst-1,4,9(11)-trien-3,17-dione, the reaction mixture
was incubated for 16 h, and the conversion ratio of androst-
1,4,9(11)-trien-3,17-dione in the products reached the
highest conversion rate (96%). The property of KstD3gor-
expressing E. coli cells to catalyze the dehydrogenation of
androst-1,4,9(11)-trien-3,17-dione was confirmed by
HPLC using androst-4,9(11)-dien-3,17-dione as a substrate
(as shown in Fig. 4). The similar results were obtained for
the clarified lysates (data not shown).







Fig. 2 Expression of catalytically active KstD3gor in BL21(DE3)
cells. a Expression of the protein analyzed by 10% SDS-PAGE: lane
1 molecular weight marker; lane 2 total cell lysate of BL21(DE3)/
pET28a-KstD3 before IPTG induction; lane 3 The total cell lysate of
the same culture as in lane 2 after IPTG induction; lane 4, the clarified
lysate of the sample in lane 3. b KstD activity visualized on native
PAGE gel loaded with total cell extracts: lane 1 clarified lysate of
BL21(DE3)/pET28a cells (negative control); lane 2 clarified lysate of
BL21(DE3) cells expressing KstD3gor after 4 h induction; lane 3
clarified lysate of the same cells as in lane 2 after 8 h induction
Fig. 3 The TOF–MS spectra of
the transformed product of
androst-4,9(11)-dien-3,17-dione
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Fig. 4 HPLC analysis of
steroid substrates bioconversion
by KstD3gor-expressing E. coli
cells. a The standard samples of
androst-4,9(11)-dien-3,17-
dione. b The standard samples
of androst-1,4,9(11)-trien-3,17-
dione. c The product by
KstD3gor-expressing E. coli
cells. d The product by
BL21(DE3)/pET28a cells
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Substrate preference and selectivity of KstD3gor
To characterize the substrate preferences of the recombi-
nant KstD3gor, nine steroid substrates were used in the
dehydrogenation reaction catalyzed by KstD3gor-expressing
cells (Table 1). The structures of the products were deter-
mined using spectroscopic techniques, The TOF–MS
spectra of the transformed products from progesterone are
shown in Fig. 3b, TOF–MS m/z: 313.21 [M?H]?,
335.19[M?Na]?. 1H NMR spectrum in CDCl3 (d, ppm):
0.70 (3H, s, H-18), 1.24 (3H, s, H-19), 2.13 (3H, s, H-21),
6.09 (1H, s, H-4), 6.30 (1H, dd, J = 10.2, 1.9 Hz, H-2),
7.04 (1H, d, J = 10 Hz, H-1). 13C NMR spectrum in
CDCl3 (d, ppm): 155.6 (C-1), 127.4 (C-2), 186.3 (C-3),
123.6 (C-4), 168.9 (C-5), 33.5 (C-6), 31.1 (C-7), 35.3 (C-
8), 55.4 (C-9), 38.5 (C-10), 22.7 (C-11), 42.9 (C-12), 43.9
(C-13), 51.9 (C-14), 22.8 (C-15), 32.5 (C-16), 62.9 (C-17),
13.8 (C-18), 18.7 (C-19), 209.2 (C-20), 24.5 (C-21). The
1HNMR, 13C NMR, and TOF–MS spectroscopic data
suggested that progesterone (pregn-4-ene-3,20-dione) was
transformed to pregn-1,4-diene-3,20-dione. The trans-
formed products of androst-4-ene-3,17-dione and 16a,17a-
epoxyprogesterone were identified as androst-1,4-diene-
3,17-dione and 16a,17-epoxypregn-1,4-diene-3,20-dione,
respectively; the spectroscopic data were as the same as our
previous reported work (Liu et al. 2011; Zhang et al. 2015).
As shown in Table 1, KstD3gor-expressing cells
exhibited the dehydrogenase activity towards androst-4-
en-3,17-dione, androst-4,9(11)-dien-3,17-dione, proges-
terone and 16a,17a-epoxyprogesterone (Fig. 5). Androst-
4-en-3,17-dione, androst-4,9(11)-dien-3,17-dione appear
to be the preferred KstD3gor substrate, with conversion
rate of 96%, respectively. However, KstD3gor-expressing
cells had no ability of catalyzing the conversion of chol-
est-4-en-3-one, (25R)-cholesten-26-oic acids, dehydroan-
drosterone, 5a-cholesteran-3b-ol, 3b-hydroxypregn-5-en-
20-one. No KstD activity was observed in negative con-
trol (data not shown).
Discussion
KstDs are widely found in actinobacteria as they play an
important role in microbial steroid degradation. Different
isoforms of the enzyme have been found exhibiting dif-
ferent substrate specificity and having different roles that
could be strain-dependent (Knol et al. 2008). The genome
of R. ruber strain Chol-4 contains three different KstD
genes, and two of them contribute to cholesterol catabolism
(Ferna´ndez de Las Heras et al. 2012). Rhodococcus jostii
RHA1 KstDs display a quite different substrate specificity
(Knol et al. 2008).
The sterol catabolic genes are highly conserved in G.
neofelifaecis, R. jostii RHA1, and Mycobacterium tuber-
culosis, and mainly organized in three specific clusters. In
our previous research, the substrate preference of five G.
neofelifaecis KstDs was investigated preliminarily (Zhang
et al. 2015). Here, the KstD3gor was biochemically char-
acterized in detail.
A phylogenetic tree (Fig. 6) of the characterized KstDs
revealed that they share high similarity with other bacterial
KstD homolog. They clustered into at least four distinct
groups (Knol et al. 2008). KstD3gor showed 63.6 and 44.7%
amino acid identity with R. ruber KstD1 and R. erythro-
polis KstD1, correspondingly. Both KstD3gor and R. ery-
thropolis KstD1 prefer 3-ketosteroids with a saturated
A-ring as substrates.
Since KstD3gor activity was not detected with trans-de-
hydroandrosterone which has no aliphatic side chain, the
3-keto-4-ene configuration of the steroid substrate appears
to be important for KstD3gor activity. KstD3gor efficiently
catalyzed the D1-dehydrogenation of steroid substrates
Table 1 Bioconversions of different kinds of steroids by recombi-
nant strain KstD3
Steroid substrate Transformation rate (%)
Androst-4-ene-3,17-dione 96.21 ± 2
4,9(11)-Androstadiene-3,17-dione 96.35 ± 2
Cholest-4-en-3-one 0
Progesterone 90.12 ± 2





1 2 3 4 5 6 7 8 9 10 
Fig. 5 TLC analysis of several steroid substrates conversion by
KstD3gor-expressing cells. Lane 1 androst-4-en-3, 17-dione; lane 2 the
conversion products of androst-4-en-3, 17-dione; lane 3 androst-
4,9(11)-dien-3,17-dione; lane 4 the conversion products of androst-
4,9(11)-dien-3,17-dione; lane 5 cholest-4-en-3-one; lane 6 the
conversion products of cholest-4-en-3-one; lane 7 progesterone; lane
8 the conversion products of progesterone; lane 9 16a,17a-epoxypro-
gesterone; lane 10 the conversion products of progesterone 16a,17a-
epoxyprogesterone
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carrying a small or no aliphatic side chain, compared to the
steroids with a bulky side chain at the C-17 atom (i.e.,
cholest-4-en-3-one, (25R)-cholesten-26-oic acid). The
conversion rate of 16a,17a-epoxyprogesterone was about
3.5-fold lower compared to that of progesterone, showing
that besides the length of the 17-alkyl side chain, the
additional molecular group in D-ring affects the catalytic
activity of KstD3gor. The 4,9(11)-dehydrogenation of
C-ring had no effect on the KstD3gor activity.
Cholest-4-en-3-one is the second intermediate product
of cholesterol catabolism (Knol et al. 2008), and (25R)-
cholesten-26-oic acids are the first product of the side-
chain degradation, but KstD3gor, KstD1-3SQ1 and KstDH37Rv
could not catalyze their 1(2)-dehydrogenation. Thus, these
KstDs could act after elimination of the sterol side-chain.
The introduction of the C1-C2 double bond into ring A
of steroid could improve the biological activity of the
original steroid substrate (i.e., prednisone and pred-
nisolone) (Fokina and Donova 2003). The enzyme KstD
catalyzing this reaction has been widely characterized
during the past two decades. We studied the KstD3gor 1(2)-
dehydrogenation activity for steroids with different A-ring,
B-ring, C-ring and D-ring modifications. The results
showed that KstD3gor has high activity towards both 4-AD
and 4-pregnene-3,20-dione (progesterone) which contain
3-keto-4-ene configuration and a small or no aliphatic side
chain at the C-17 atom. It appears to be different from the
KstD1SQ1 (KstD1 from Rhodococcus erythropolis SQ1)
which shows high activity towards 4-AD but low activity
towards 4-pregnene-3,20-dione (Knol et al. 2008). While
KstD3SQ1 had a clear preference for 3-ketosteroids with a
saturated A-ring, the 1(2)-dehydrogenation of androst-
4,9(11)-dien-3,17-dione is one step of the pathway for
glucocorticoid production (Fig. 1). This pathway is con-
sidered to be an effective method to produce fluorocorti-
coids (such as dexamethasone, betamethasone,
triamcinolone, etc.) and other valuable steroid drugs
(Fokina and Donova 2003). But the application of KstD for
the 1(2)-dehydrogenation of androst-4,9(11)-dien-3,17-
dione [4,9(11)-AD] has not been tested. The conversion
rate of androst-4,9(11)-dien-3,17-dione to androst-
1,4,9(11)-trien-3,17-dione by the KstD3gor-expressing cells
was more than 96%. Thus, this work provided a candidate,
KstD3gor-expressing cells, for the industrial conversion of
steroids to their 1(2)-dehydro-analogs.
In summary, the KstD3gor from G. neofelifaecis was
expressed efficiently in a soluble form in E. coli. The
KstD3gor-expressing cells effectively converted androst-
4,9(11)-dien-3,17-dione and androst-4-en-3, 17-dione to
androst-1,4,9(11)-trien-3,17-dione and androst-1,4-en-
3,17-dione, respectively. Both of them can be recom-
mended as substrate for 1(2)-dehydrogenation by KstD3gor-
expressing E. coli in the commercial production of
9-halogenated steroids.
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